Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: M. Ramle who wrote (838)	5/5/1998 8:53:00 PM
From: billy d	Read Replies (1) \| Respond to of 10280

I'm still not concerned Mazen. Almost every biotech was down today. AGPH happened to be up on news of a new cancer trial (quite timely on their part) but that was up almost 5 points at one time and ended up a bit over 2 points. I guess we come from different schools of technical trading but I still feel that this market is VERY sector driven and that is a very important thing to keep in mind. How well your stock does relative to its sector is very important. I too would like to see more volume but the real key to me is no one is rushing to the door to get out of SEPR. We are making a slow but sure move upward. Over the last few days it was vogue to buy the companies who are doing cancer trials on mice, which buy the way even if effective in mice have a 10,000 to 1 chance of making it to market. This is a fact. Although they may not sporting a product that could cure cancer and as far as biotech goes may seem "boring", SEPR's pipeline is loaded with potential blockbusters. In time I believe many others in the investing community will see this. Good luck to all.